Scientists have developed a modified algae strain that attracts and traps microscopic plastic particles, offering a potential biological answer to a widespread and stubborn form of pollution.
Modified algae trap microplastics through surface adhesion properties.
The method could be integrated into drinking water treatment plants.
Research remains at laboratory stage; industrial-scale tests have not begun.
Beyond their well-documented benefits and known adverse effects, researchers flag an additional, less visible risk for patients on weight-reduction treatments.
Weight-loss drugs can carry less visible side effects beyond those already well established.
Muscle-mass loss is a documented risk when treatment is not accompanied by proper supervision.
Specialists recommend monitoring body composition throughout any such treatment course.
CAR-T cell therapy, already used in oncology, is now being tested against multiple sclerosis, lupus and other conditions where the immune system attacks the body itself.
CAR-T therapy, established in oncology, is now being trialled in serious autoimmune conditions.
Some patients with severe lupus have achieved complete remission after a single administration.
High costs and procedural complexity currently limit broad access to the treatment.
A new study suggests that original biological material can survive fossilisation over tens of millions of years — upending a long-held assumption in palaeontology.
Original organic molecules identified inside dinosaur fossils tens of millions of years old.
Finding challenges the classic view that fossilisation fully destroys biological material.
New pathways open for studying the biochemistry of long-extinct prehistoric species.
An unusual cluster of cases aboard an expedition vessel has reignited calls for vaccines and specific treatments against a virus that currently has neither.
An unusual hantavirus cluster on the MV Hondius has alarmed international health authorities.
No approved vaccine or antiviral exists; severe-form mortality can exceed 30%.
WHO faces renewed pressure to accelerate funding and strengthen surveillance protocols.